Document:

exv10w1

Exhibit 10.1

MYLAN INC.

7.625% Senior Notes due 2017

7.875% Senior Notes due 2020

 

Purchase Agreement

May 12, 2010

Goldman, Sachs & Co.,

   As Representative of the several Purchasers

   named in Schedule I hereto,

200 West Street,

New York, New York 10282-2198

Ladies and Gentlemen:

          Mylan Inc., a Pennsylvania corporation (the “Company”), proposes, subject to the terms and
conditions stated herein, to issue and sell to the Purchasers named in Schedule I hereto (the
“Purchasers”) an aggregate of $550,000,000 principal amount of its 7.625% Senior Notes due 2017
(the “2017 Notes”) and an aggregate of $700,000,000 principal amount of its 7.875% Senior Notes due
2020 (the “2020 Notes” and, together with the 2017 Notes, the “Securities”). The Securities will
be issued pursuant to an indenture, dated as of the Time of Delivery (as defined in Section 4(a)
hereof) (the “Indenture”), that will be entered into among the Company, the Guarantors (as defined
below) and The Bank of New York Mellon, as trustee (the “Trustee”). The Company’s obligations
under the Securities will be irrevocably and unconditionally guaranteed (the “Guarantees”) as to
the payment of principal, premium and interest on a senior basis, jointly and severally, initially
by each of the subsidiary guarantors listed on the signature pages of this Agreement (each a
“Guarantor” and, collectively, the “Guarantors”). This Agreement, the Securities, the Guarantees
and the Indenture are collectively referred to herein as the “Transaction Documents.”

1. The Company and each Guarantor represent and warrant to, and agree with, each of the Purchasers
that:

     (a) A preliminary offering circular, dated May 4, 2010 (the “Preliminary Offering Circular”)
and an offering circular, dated May 12, 2010 (the “Offering Circular”), have been prepared in
connection with the offering of the Securities. The Preliminary Offering Circular, as amended and
supplemented immediately prior to the Applicable Time (as defined in Section 1(b)), is hereinafter
referred to the “Pricing Circular.” Any reference to the Preliminary Offering Circular, the
Pricing Circular or the Offering Circular shall be deemed to refer to and include the Company’s
most recent Annual Report on Form 10-K and all subsequent documents filed with the United States
Securities and Exchange Commission (the “Commission”) pursuant to Section 13(a), 13(c) or 15(d) of
the United States Securities Exchange Act of 1934, as amended (the “Exchange Act”) on or prior to
the date of such circular and any reference to the Preliminary Offering Circular or the Offering
Circular, as the case may be, as amended or supplemented, as of any specified date, shall be deemed
to include (i) any documents filed with the Commission pursuant to Section 13(a), 13(c) or 15(d) of
the Exchange

 

 

Act after the date of the Preliminary Offering Circular or the Offering Circular, as the case
may be, and prior to such specified date and (ii) any Additional Issuer Information (as defined in
Section 5(f)) furnished by the Company prior to the completion of the distribution of the
Securities; and all documents filed under the Exchange Act and so deemed to be included in the
Preliminary Offering Circular, the Pricing Circular or the Offering Circular, as the case may be,
or any amendment or supplement thereto are hereinafter called the “Exchange Act Reports”. The
Exchange Act Reports, when they were or are filed with the Commission, conformed or will conform in
all material respects to the applicable requirements of the Exchange Act and the applicable rules
and regulations of the Commission thereunder; and no such documents were filed with the Commission
since the Commission’s close of business on the business day immediately prior to the date of this
Agreement and prior to the execution of this Agreement, except as set forth on Schedule II(a)
hereof. The Preliminary Offering Circular or the Offering Circular and any amendments or
supplements thereto and the Exchange Act Reports did not and will not, as of their respective
dates, contain an untrue statement of a material fact or omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; provided, however, that this representation and warranty shall not apply to any
statements or omissions made in reliance upon and in conformity with information furnished in
writing to the Company by a Purchaser through the Representative expressly for use therein;

     (b) For the purposes of this Agreement, the “Applicable Time” is 4:00 pm (Eastern time) on the
date of this Agreement; the Pricing Circular as supplemented by the information set forth in
Schedule III hereto, taken together (collectively, the “Pricing Disclosure Package”) as of
the Applicable Time, did not include any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; and each Company Supplemental Disclosure Document (as
defined in Section 6(a)) listed on Schedule II(b) hereto does not conflict with the
information contained in the Pricing Circular or the Offering Circular and each such Company
Supplemental Disclosure Document, as supplemented by and taken together with the Pricing Disclosure
Package as of the Applicable Time, did not include any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided, however, that this
representation and warranty shall not apply to statements or omissions made in a Company
Supplemental Disclosure Document in reliance upon and in conformity with information furnished in
writing to the Company by a Purchaser through the Representative expressly for use therein;

     (c) Deloitte & Touche LLP, the accountants who certified the financial statements and
supporting schedules included or incorporated by reference in the Offering Circular and the Pricing
Circular are independent public accountants with respect to the Company and its subsidiaries within
the meaning of the United States Securities Act of 1933, as amended (the “Securities Act”) and the
rules and regulations thereunder;

     (d) The financial statements of the Company included in the Pricing Circular and the Offering
Circular, together with the related schedules and notes, present fairly the financial position of
the Company and its consolidated subsidiaries at the dates indicated and the results of operations,
stockholders’ equity and cash flows of the Company and its consolidated subsidiaries for the
periods specified; said financial statements have been prepared in conformity with generally
accepted accounting principles (“GAAP”) applied on a consistent basis throughout the periods
involved. The supporting schedules, if any, included in the Pricing Circular and the Offering
Circular present fairly in accordance with GAAP the information required to be stated therein. The
selected financial data and

2

 

the summary financial information of the Company included in the Pricing Circular and the
Offering Circular present fairly the information shown therein and have been compiled on a basis
consistent with that of the audited financial statements of the Company incorporated by reference
in the Pricing Circular and the Offering Circular;

     (e) Since the respective dates as of which information is given in the Pricing Circular and
the Offering Circular, except as otherwise stated therein, (i) there has not been any change in the
capital stock or long-term debt of the Company or any of its subsidiaries, or any material adverse
change in the condition, financial or otherwise, results of operations, business affairs or
business prospects of the Company and its subsidiaries considered as one enterprise, whether or not
arising in the ordinary course of business (a “Material Adverse Effect”), and (ii) there have been
no transactions entered into by the Company or any of its subsidiaries, other than those in the
ordinary course of business, which are material with respect to the Company and its subsidiaries
considered as one enterprise;

     (f) The Company has been duly organized and is validly existing as a corporation in good
standing under the laws of the Commonwealth of Pennsylvania and has corporate power and authority
to own, lease and operate its properties and to conduct its business as described in the Pricing
Circular and the Offering Circular and to enter into and perform its obligations under this
Agreement; and the Company is duly qualified as a foreign corporation to transact business and is
in good standing in each other jurisdiction in which such qualification is required, whether by
reason of the ownership or leasing of property or the conduct of business, except where the failure
to so qualify would not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect;

     (g) Each Designated Subsidiary (as defined below) has been duly organized and is validly
existing as a corporation, limited partnership or limited liability company in good standing under
the laws of the jurisdiction of its formation, has corporate or other power and authority to own,
lease and operate its properties and to conduct its business as described in the Pricing Circular
and the Offering Circular and is duly qualified as a foreign corporation or limited liability
company to transact business and is in good standing in each jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of property or the conduct
of business, except where the failure to so qualify would not, individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect; except as otherwise disclosed in the
Pricing Circular and the Offering Circular, all of the issued and outstanding capital stock of each
Designated Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable
and is owned by the Company, directly or through subsidiaries, free and clear of any security
interest, mortgage, pledge, lien, encumbrance, claim or equity; none of the outstanding shares of
capital stock of the Designated Subsidiaries was issued in violation of any preemptive or similar
rights of any securityholder of such Designated Subsidiary. “Designated Subsidiary” means (a) each
Guarantor and (b) each other direct or indirect subsidiary of the Company that holds at least 5% of
the consolidated total assets of the Company or accounts for at least 5% of the consolidated total
revenues of the Company;

     (h) The authorized, issued and outstanding capital stock of the Company is as set forth in the
Pricing Circular and the Offering Circular. The shares of issued and outstanding capital stock of
the Company have been duly authorized and validly issued and are fully paid and non-assessable; and
none of the outstanding shares of capital stock of the Company was issued in violation of the
preemptive or other similar rights of any securityholder of the Company;

     (i) This Agreement has been duly authorized, executed and delivered by the Company and each of
the Guarantors;

3

 

     (j) The Indenture has been duly authorized by the Company and each of the Guarantors and, when
executed and delivered by the Company and each of the Guarantors (assuming the due authorization,
execution and delivery thereof by the Trustee), will have been duly executed and delivered and will
constitute a valid and binding agreement of the Company and each of the Guarantors, enforceable
against the Company and each of the Guarantors in accordance with its terms, except as the
enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all
laws relating to fraudulent transfers), reorganization, moratorium or similar laws affecting
enforcement of creditors’ rights generally and except as enforcement thereof is subject to general
principles of equity (regardless of whether enforcement is considered in a proceeding in equity or
at law);

     (k) The Securities have been duly authorized and, when the notes representing the Securities
are executed and authenticated in the manner provided for in the Indenture and delivered against
payment of the purchase price therefor as provided in this Agreement, will constitute valid and
binding obligations of the Company, enforceable against the Company in accordance with their terms,
except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without
limitation, all laws relating to fraudulent transfers) reorganization, moratorium or similar laws
affecting enforcement of creditors’ rights generally and except as enforcement thereof is subject
to general principles of equity (regardless of whether enforcement is considered in a proceeding in
equity or at law), and will be in the form contemplated by, and entitled to the benefits of, the
Indenture;

     (l) The Guarantees have been duly authorized and, when executed in the manner provided for in
the Indenture as provided in this Agreement, will constitute valid and binding obligations of the
Guarantors, enforceable against the Guarantors in accordance with their terms, except as the
enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all
laws relating to fraudulent transfers) reorganization, moratorium or similar laws affecting
enforcement of creditors’ rights generally and except as enforcement thereof is subject to general
principles of equity (regardless of whether enforcement is considered in a proceeding in equity or
at law), and will be in the form contemplated by, and entitled to the benefits of, the Indenture;

     (m) The Securities, the Indenture and the Guarantees will conform in all material respects to
the respective statements relating thereto contained in the Pricing Circular and the Offering
Circular and will be in substantially the respective forms last delivered to the Purchasers prior
to the date of this Agreement;

     (n) Neither the Company nor any of its subsidiaries is (a) in violation of its charter or
by-laws or (b) in default in the performance or observance of any obligation, agreement, covenant
or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit
agreement, note, lease or other agreement or instrument to which the Company or any of its
subsidiaries is a party or by which it or any of them may be bound, or to which any of the property
or assets of the Company or any of its subsidiaries is subject (collectively, “Agreements and
Instruments”) except in the case of this clause (b) for defaults that would not, individually or in
the aggregate, reasonably be expected to result in a Material Adverse Effect;

     (o) The execution, delivery and performance of this Agreement, the Indenture and the
Securities and any other agreement or instrument entered into or issued or to be entered into or
issued by the Company or the Guarantors in connection with the transactions contemplated hereby or
thereby or in the Pricing Circular and the Offering Circular and the consummation of the
transactions contemplated herein and in the Pricing Circular and the Offering Circular (including
the issuance and sale of the Securities and the use of the proceeds from the sale of the Securities
as described in the Pricing Circular and the Offering Circular under the caption “Use of Proceeds”)
and compliance by the

4

 

Company and the Guarantors with their obligations hereunder have been duly authorized by all
necessary corporate or other action and do not and will not, whether with or without the giving of
notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment
Event (as defined below) under, or result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, the
Agreements and Instruments except for such conflicts, breaches or defaults or Repayment Events or
liens, charges or encumbrances that would not, individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect, nor will such action result in any violation of
(x) the provisions of the charter or by-laws of the Company or any of its subsidiaries or (y) any
applicable law, statute, rule, regulation, judgment, order, writ or decree of any government,
government instrumentality or court, domestic or foreign, having jurisdiction over the Company or
any of its subsidiaries or any of their assets, properties or operations, except in the case of
clause (y) above, any such violations that would not, individually or in the aggregate, reasonably
be expected to result in a Material Adverse Effect. As used herein, a “Repayment Event” means any
event or condition which gives the holder of any note, debenture or other evidence of indebtedness
(or any person acting on such holder’s behalf) the right to require the repurchase, redemption or
repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries;

     (p) No labor dispute with the employees of the Company or any of its subsidiaries exists or,
to the knowledge of the Company, is imminent, and the Company is not aware of any existing or
imminent labor disturbance by the employees of any of its or any subsidiary’s principal suppliers,
manufacturers, customers or contractors, except such disputes or disturbances that would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;

     (q) Except as described in the Pricing Circular and the Offering Circular and except such
matters as would not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect, neither the Company nor any of its subsidiaries is in violation of any
federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of
common law or any judicial or administrative interpretation thereof, including any judicial or
administrative order, consent, decree or judgment. Except as described in the Pricing Circular and
the Offering Circular, there is no action, suit, proceeding, inquiry or investigation before or
brought by any court or governmental agency or body, domestic or foreign, now pending, or, to the
knowledge of the Company, threatened or contemplated, against or affecting the Company or any of
its subsidiaries that would, individually or in the aggregate, reasonably be expected to result in
a Material Adverse Effect, or which might materially and adversely affect the consummation of the
transactions contemplated by this Agreement or the performance by the Company of its obligations
hereunder. The aggregate of all pending legal or governmental proceedings to which the Company or
any of its subsidiaries is a party or of which any of their respective property or assets is the
subject which are not described in the Pricing Circular and the Offering Circular, including
ordinary routine litigation incidental to the business, could not reasonably be expected to result
in a Material Adverse Effect;

     (r) All United States federal income tax returns of the Company and its subsidiaries required
by law to be filed have been filed or extensions thereof have been duly requested and all taxes
shown by such returns or otherwise assessed, which are due and payable, have been paid, except
assessments against which appeals have been or will be promptly taken and as to which adequate
reserves have been provided or where the failure to pay would not, individually or in the
aggregate, reasonably be expected to result in a Material Adverse Effect. The Company and its
subsidiaries have filed all other tax returns that are required to have been filed by them pursuant
to applicable foreign, state, local or other law except insofar as the failure to file such returns
would not, individually

5

 

or in the aggregate, reasonably be expected to result in a Material Adverse Effect, and have
paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company
and its subsidiaries, except for such taxes, if any, as are being contested in good faith and as to
which adequate reserves have been provided or where the failure to pay would not, individually or
in the aggregate, reasonably be expected to result in a Material Adverse Effect. The charges,
accruals and reserves on the books of the Company in respect of any income and corporation tax
liability for any years not finally determined are adequate to meet any assessments or
re-assessments for additional income tax for any years not finally determined, except to the extent
of any inadequacy that would not, individually or in the aggregate, reasonably be expected to
result in a Material Adverse Effect;

     (s) The Company and its subsidiaries maintain a system of internal control over financial
reporting (as such term is defined in Rule 13a—15(f) of the Exchange Act) that complies with the
requirements of the Exchange Act, designed by, or under the supervision of, the Company’s principal
executive officer and principal financial officer, or persons performing similar functions,
sufficient to provide reasonable assurances that (A) transactions are executed in accordance with
management’s general or specific authorization, (B) transactions are recorded as necessary to
permit preparation of financial statements for external purposes in conformity with GAAP and to
maintain accountability for assets, (C) access to assets is permitted only in accordance with
management’s general or specific authorization and (D) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences. The Company’s internal control over financial reporting is effective
and the Company is not aware of any material weaknesses in its internal control over financial
reporting. Since the date of the latest audited financial statements included or incorporated by
reference in the Pricing Circular, there has been no change in the Company’s internal control over
financial reporting that has materially affected, or is reasonably likely to materially affect, the
Company’s internal control over financial reporting;

     (t) The Company maintains disclosure controls and procedures (as such term is defined in Rule
13a-15(e) under the Exchange Act) that comply with the requirements of the Exchange Act; such
disclosure controls and procedures have been designed to ensure that material information relating
to the Company and its subsidiaries is made known to the Company’s principal executive officer and
principal financial officer by others within those entities; and such disclosure controls and
procedures are effective;

     (u) The Company and its subsidiaries carry or are entitled to the benefits of insurance, with
financially sound and reputable insurers, in such amounts and covering such risks as is generally
maintained by companies of established repute engaged in the same or similar business, and all such
insurance is in full force and effect;

     (v) The Company is, and immediately after the Time of Delivery will be, Solvent. As used
herein, the term “Solvent” means, with respect to the Company on a particular date, that on such
date (A) the fair market value of the assets of the Company is greater than the total amount of
liabilities (including contingent liabilities) of the Company, (B) the present fair salable value
of the assets of the Company is greater than the amount that will be required to pay the probable
liabilities of the Company on its debts as they become absolute and matured, (C) the Company is
able to realize upon its assets and pay its debts and other liabilities, including contingent
obligations, as they mature, and (D) the Company does not have unreasonably small capital;

     (w) Neither the Company nor any affiliate of the Company has taken, nor will the Company or
any affiliate take, directly or indirectly, any action which is designed to or which has
constituted or which would be expected to cause or result in stabilization or manipulation of the
price of any security of the Company to facilitate the sale or resale of the Securities;

6

 

     (x) Except as described in Disclosure Package and the Final Offering Memorandum, the Company
and its subsidiaries own or possess, or can acquire on reasonable terms, adequate patents, patent
rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or procedures), trademarks,
service marks, trade names or other intellectual property (collectively, “Intellectual Property”)
necessary to carry on the business now operated by them, and neither the Company nor any of its
subsidiaries has received any notice or is otherwise aware of any infringement of or conflict with
asserted rights of others with respect to any Intellectual Property or of any facts or
circumstances which would render any Intellectual Property invalid or inadequate to protect the
interest of the Company or any of its subsidiaries therein, and which infringement or conflict (if
the subject of any unfavorable decision, ruling or finding) or invalidity or inadequacy would,
individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect;

     (y) Except as disclosed in the Pricing Circular and the Offering Circular and other than
registration or qualification under state securities or blue sky laws in connection with the offer
and sale of the Securities, no filing with, or authorization, approval, consent, license, order,
registration, qualification or decree of, any court or governmental authority or agency is
necessary or required for the performance by the Company of its obligations hereunder, in
connection with the offering, issuance or sale of the Securities hereunder or the consummation of
the transactions contemplated by this Agreement or for the due execution, delivery or performance
of the Indenture by the Company and the Guarantors, except such as have been already obtained;

     (z) Except as described in the Pricing Circular and the Offering Circular, the Company and its
subsidiaries possess such permits, licenses, approvals, consents and other authorizations
(collectively, “Governmental Licenses”) issued by the appropriate federal, state, local or foreign
regulatory agencies or bodies necessary to conduct the business now operated by them, except where
the failure to so possess would not, individually or in the aggregate, reasonably be expected to
result in a Material Adverse Effect; the Company and its subsidiaries are in compliance with the
terms and conditions of all such Governmental Licenses, except where the failure to so comply would
not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
Effect; all of the Governmental Licenses are valid and in full force and effect, except where the
invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full
force and effect would not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect; and neither the Company nor any of its subsidiaries has received any
notice of proceedings relating to the revocation or modification of any such Governmental Licenses
which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or
finding, would reasonably be expected to result in a Material Adverse Effect;

     (aa) The Company and its subsidiaries have good and marketable title to all real property
owned by the Company and its subsidiaries and good and marketable title to all other properties
owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests,
claims, restrictions or encumbrances of any kind except such as (a) are described in the Pricing
Circular and the Offering Circular or (b) do not, individually or in the aggregate, materially
affect the value of such property and do not interfere with the use made and proposed to be made of
such property by the Company or any of its subsidiaries; and all of the leases and subleases under
which the Company or any of its subsidiaries holds properties described in the Pricing Circular and
the Offering Circular, are in full force and effect, except where the failure of such lease or
sublease to be in full force and effect would not, individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect, and neither the Company nor any of its
subsidiaries has any notice of any

7

 

material claim of any sort that has been asserted by anyone adverse to the rights of the
Company or any of its subsidiaries under any of the leases or subleases mentioned above, or
affecting or questioning the rights of the Company or any subsidiary thereof to the continued
possession of the leased or subleased premises under any such lease or sublease;

     (bb) Except as would not, individually or in the aggregate, reasonably be expected to result
in a Material Adverse Effect, no supplier of merchandise to the Company or any of its subsidiaries
has ceased shipments of merchandise to the Company;

     (cc) Except as described in the Pricing Circular and the Offering Circular and except such
matters as would not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect, (A) neither the Company nor any of its subsidiaries is in violation of any
federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of
common law or any judicial or administrative interpretation thereof, including any judicial or
administrative order, consent, decree or judgment, relating to pollution or protection of human
health, the environment (including, without limitation, ambient air, surface water, groundwater,
land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations
relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic
substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or
mold (collectively, “Hazardous Materials”) or to the manufacture, processing, distribution, use,
treatment, storage, disposal, transport or handling of Hazardous Materials (collectively,
“Environmental Laws”), (B) the Company and its subsidiaries have all permits, authorizations and
approvals required under any applicable Environmental Laws and are each in compliance with their
requirements, (C) there are no pending or, to the Company’s knowledge, threatened administrative,
regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of
noncompliance or violation, investigation or proceedings relating to any Environmental Law against
the Company or any of its subsidiaries and (D) there are no events or circumstances that would
reasonably be expected to form the basis of an order for clean-up or remediation, or any action,
suit or proceeding by any private party or governmental body or agency, against or affecting the
Company or any of its subsidiaries relating to Hazardous Materials or Environmental Laws;

     (dd) The Company is not required, and upon the issuance and sale of the Securities as herein
contemplated and the application of the net proceeds therefrom as described in the Pricing Circular
and the Offering Circular will not be required, to register as an “investment company” under the
Investment Company Act of 1940, as amended (the “Investment Company Act”);

     (ee) Neither the Company nor any of its affiliates, as such term is defined in Rule 501(b) of
Regulation D under the Securities Act (“Regulation D”) (each, an “Affiliate”), has, directly or
indirectly, solicited any offer to buy, sold or offered to sell or otherwise negotiated in respect
of, nor will, directly or indirectly, solicit any offer to buy, sell or offer to sell or otherwise
negotiate in respect of, in the United States or to any United States citizen or resident, any
security which is or would be integrated with the sale of the Securities or the Guarantees in a
manner that would require the Securities or the Guarantees to be registered under the Securities
Act;

     (ff) The Securities are eligible for resale pursuant to Rule 144A and will not be, at the Time
of Delivery, of the same class (within the meaning of Rule 144A of the Securities Act) as
securities listed on a national securities exchange registered under Section 6 of the Exchange Act
or quoted in a U.S. automated interdealer quotation system;

     (gg) None of the Company, its Affiliates or any person acting on its or any of their behalf
(other than the Purchasers, as to whom the Company makes no representation) has engaged or will

8

 

engage, in connection with the offering of the Securities, in any form of general solicitation
or general advertising within the meaning of Rule 502(c) under the Securities Act, or, with respect
to Securities sold outside the United States to non-U.S. persons (as defined in Rule 902 under the
Securities Act), by means of any directed selling efforts within the meaning of Rule 902 under the
Securities Act and the Company, any Affiliate of the Company and any person acting on its or any of
their behalf (other than the Purchasers, as to whom the Company makes no representation) has
complied with and will implement the “offering restrictions” within the meaning of such Rule 902;

     (hh) Subject to compliance by the Purchasers with the representations and warranties set forth
in Section 2, it is not necessary in connection with the offer, sale and delivery of the Securities
to the Purchasers and to each subsequent purchaser in the manner contemplated by this Agreement,
the Pricing Circular and the Offering Circular to register the Securities under the Securities Act
or to qualify the Indenture under the Trust Indenture Act of 1939, as amended;

     (ii) The statements set forth in the Pricing Circular and Offering Circular under the caption
“Description of Notes”, insofar as they purport to constitute a summary of the terms of the
Securities, are accurate, complete and fair in all material respects;

     (jj) The Company is subject to Section 13 or 15(d) of the Exchange Act;

     (kk) Except as would not, individually or in the aggregate, reasonably be expected to result
in a Material Adverse Effect, (a) none of the Company, any of its subsidiaries or, to the knowledge
of the Company, any director, officer, agent, employee or affiliate is aware of or has taken any
action, directly or indirectly, that would result in a violation by such persons of the Foreign
Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”);
and (b) the Company and, to the knowledge of the Company, its affiliates have conducted their
businesses in compliance with the FCPA and have instituted and maintain policies and procedures
designed to ensure, and which are reasonably expected to continue to ensure, continued compliance
therewith; and

     (ll) None of the Company, any of its subsidiaries or, to the knowledge of the Company, any
director, officer, agent, employee or affiliate is currently subject to any U.S. sanctions
administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)
except as would not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect; and the Company will not directly or indirectly use the proceeds of the
sale of the Securities, or lend, contribute or otherwise make available such proceeds to any of its
subsidiaries, joint venture partners or other person, for the purpose of financing the activities
of any person currently subject to any U.S. sanctions administered by OFAC.

2. Subject to the terms and conditions herein set forth, the Company agrees to issue and sell to
each of the Purchasers, and each of the Purchasers agrees, severally and not jointly, to purchase
from the Company, (a) at a purchase price of 98.472% of the principal amount thereof, the principal
amount of the 2017 Notes set forth opposite the name of such Purchaser in Schedule I(a) hereto and
(b) at a purchase price of 98.470% of the principal amount thereof, the principal amount of the
2020 Notes set forth opposite the name of such Purchaser in Schedule I(b) hereto.

	3.	 	Upon the authorization by you of the release of the Securities, the several Purchasers
propose to offer the Securities for sale upon the terms and conditions set forth in this
Agreement and the Offering Circular and each Purchaser hereby represents and warrants to, and
agrees with the Company and each Guarantor that:

9

 

	 	(a)	 	It will offer and sell the Securities only to:(i) persons who it reasonably believes
are “qualified institutional buyers” (“QIBs”) within the meaning of Rule 144A under the
Securities Act in transactions meeting the requirements of Rule 144A or (ii) upon the terms
and conditions set forth in Annex I to this Agreement;
	 
	 	(b)	 	It is an Institutional Accredited Investor within the meaning of Rule 501(a) under the
Securities Act; and
	 
	 	(c)	 	It will not offer or sell the Securities by any form of general solicitation or general
advertising, including but not limited to the methods described in Rule 502(c) under the
Securities Act.
	 
	4.	(a)	 	The Securities to be purchased by each Purchaser hereunder will be represented by one or
more definitive global Securities in book-entry form which will be deposited by or on behalf
of the Company with The Depository Trust Company (“DTC”) or its designated custodian. The
Company will deliver the Securities to the Representative, for the account of each Purchaser,
against payment by or on behalf of such Purchaser of the purchase price therefor by wire
transfer in Federal (same day) funds, by causing DTC to credit the Securities to the account
of the Representative at DTC. The Company will cause the certificates representing the
Securities to be made available to the Representative for checking at least twenty-four hours
prior to the Time of Delivery (as defined below) at the office of Latham & Watkins LLP, 885
Third Avenue, New York, NY 10022-4834 (the “Closing Location”). The time and date of such
delivery and payment shall be 9:30 a.m., New York City time, on May 19, 2010 or such other
time and date as the Representative and the Company may agree upon in writing. Such time and
date are herein called the “Time of Delivery”.
	 
	 	(b)	 	The documents to be delivered at the Time of Delivery by or on behalf of the parties
hereto pursuant to Section 8 hereof, including the cross-receipt for the Securities and any
additional documents requested by the Purchasers pursuant to Section 8(g) hereof, will be
delivered at such time and date at the Closing Location, and the Securities will be
delivered at DTC or its designated custodian, all at the Time of Delivery. A meeting will
be held at the Closing Location at 5:00 p.m., New York City time, on the New York Business
Day next preceding the Time of Delivery, at which meeting the final drafts of the documents
to be delivered pursuant to the preceding sentence will be available for review by the
parties hereto. For the purposes of this Section 4, “New York Business Day” shall mean
each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking
institutions in New York are generally authorized or obligated by law or executive order to
close.

	5.	 	The Company and each Guarantor agree, jointly and severally, with each of the Purchasers:

	 	(a)	 	To prepare the Offering Circular in a form approved by you; to make no amendment or any
supplement to the Offering Circular which shall be disapproved by you promptly after
reasonable notice thereof; and to furnish you with copies thereof;
	 
	 	(b)	 	Promptly from time to time to take such action as you may reasonably request to qualify
the Securities for offering and sale under the securities laws of such jurisdictions as you
may request and to comply with such laws so as to permit the continuance of sales and
dealings therein in such jurisdictions for as long as may be necessary to complete the
distribution of the Securities, provided that in connection therewith the Company shall not
be required to qualify as a foreign corporation or to file a general consent to service of
process in any jurisdiction or to subject itself to taxation as a foreign corporation in
such jurisdiction if it is not otherwise so subject;

10

 

	 	(c)	 	To furnish the Purchasers with written and electronic copies thereof in such quantities
as you may from time to time reasonably request, and if, at any time prior to the
expiration of nine months after the date of the Offering Circular, any event shall have
occurred as a result of which the Offering Circular as then amended or supplemented would
include an untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements therein, in the light of the circumstances under which they
were made when such Offering Circular is delivered, not misleading, or, if for any other
reason it shall be necessary or desirable during such same period to amend or supplement
the Offering Circular, to notify you and upon your request to prepare and furnish without
charge to each Purchaser and to any dealer in securities as many written and electronic
copies as you may from time to time reasonably request of an amended Offering Circular or a
supplement to the Offering Circular which will correct such statement or omission or effect
such compliance;
	 
	 	(d)	 	During the period beginning from the date hereof and continuing until the date 90 days
after the Time of Delivery, not to offer, sell, contract to sell or otherwise dispose of,
except as provided hereunder any securities of the Company that are substantially similar
to the Securities without the prior written consent of the Representative;
	 
	 	(e)	 	Not to be or become, at any time prior to the expiration of two years after the Time of
Delivery, an open-end investment company, unit investment trust, closed-end investment
company or face-amount certificate company that is or is required to be registered under
Section 8 of the Investment Company Act;
	 
	 	(f)	 	At any time when the Company is not subject to Section 13 or 15(d) of the Exchange Act,
for the benefit of holders from time to time of Securities, to furnish at its expense, upon
request, to holders of Securities and prospective purchasers of securities information (the
“Additional Issuer Information”) satisfying the requirements of subsection (d)(4)(i) of
Rule 144A under the Securities Act;
	 
	 	(g)	 	Until the offering of the Securities is complete, the Company will file all documents
required to be filed with the Commission pursuant to the Exchange Act within the time
periods required by the Exchange Act;
	 
	 	(h)	 	During the one year period after the Time of Delivery, the Company will not, and will
not permit any of its “affiliates” (as defined in Rule 144 under the Securities Act) to,
resell any of the Securities which constitute “restricted securities” under Rule 144 that
have been reacquired by any of them; and
	 
	 	(i)	 	To use the net proceeds received by it from the sale of the Securities pursuant to this
Agreement in the manner specified in the Pricing Circular under the caption “Use of
Proceeds.”
	 
	6.	 	 	 
	 
	 	(a)	 	The Company and each Guarantor represent and agree that, without the prior consent of
the Representative, it has not made and will not make any offer relating to the Securities
that, if the offering of the Securities contemplated by this Agreement were conducted as a
public offering pursuant to a registration statement filed under the Securities Act with
the Commission, would constitute an “issuer free writing prospectus,” as defined in Rule
433 under the Securities Act (any such offer is hereinafter referred to as a “Company
Supplemental Disclosure Document”);

11

 

	 	(b)	 	Each Purchaser represents and agrees that, without the prior consent of the Company and
the Representative, other than one or more term sheets relating to the Securities
containing customary information and conveyed to purchasers of securities, it has not made
and will not make any offer relating to the Securities that, if the offering of the
Securities contemplated by this Agreement were conducted as a public offering pursuant to a
registration statement filed under the Securities Act with the Commission, would constitute
a “free writing prospectus,” as defined in Rule 405 under the Securities Act (any such
offer (other than any such term sheets), is hereinafter referred to as a “Purchaser
Supplemental Disclosure Document”); and
	 
	 	(c)	 	Any Company Supplemental Disclosure Document or Purchaser Supplemental Disclosure
Document, the use of which has been consented to by the Company and the Representative, is
listed on Schedule II(b) hereto.

	7.	 	The Company and each Guarantor, jointly and severally, covenant and agree with the several
Purchasers that the Company will pay or cause to be paid the following: (i) the fees,
disbursements and expenses of the Company’s and the Guarantors’ counsel and accountants in
connection with the issue of the Securities and all other expenses in connection with the
preparation, printing, reproduction and filing of the Preliminary Offering Circular and the
Offering Circular and any amendments and supplements thereto and the mailing and delivering of
copies thereof to the Purchasers and dealers; (ii) the cost of printing or producing, this
Agreement, the Indenture, the Blue Sky Memorandum, closing documents (including any
compilations thereof) and any other documents in connection with the offering, purchase, sale
and delivery of the Securities; (iii) all expenses in connection with the qualification of the
Securities for offering and sale under state securities laws as provided in Section 5(b)
hereof, including the reasonable fees and disbursements of counsel for the Purchasers in
connection with such qualification and in connection with the Blue Sky and legal investment
surveys; (iv) any fees charged by securities rating services for rating the Securities; (v)
the cost of preparing the Securities; (vi) the fees and expenses of the Trustee and any agent
of the Trustee and the fees and disbursements of counsel for the Trustee in connection with
the Indenture and the Securities; and (vii) all other costs and expenses incident to the
performance of its obligations hereunder which are not otherwise specifically provided for in
this Section. It is understood, however, that, except as provided in this Section, and
Sections 9 and 12 hereof, the Purchasers will pay all of their own costs and expenses,
including the fees of their counsel, transfer taxes on resale of any of the Securities by
them, and any advertising expenses connected with any offers they may make.
	 
	8.	 	The obligations of the Purchasers hereunder shall be subject, in their discretion, to the
condition that all representations and warranties and other statements of the Company and each
Guarantor herein are, at and as of the Time of Delivery, true and correct, the condition that
the Company and each Guarantor shall have performed all of its obligations hereunder
theretofore to be performed, and the following additional conditions:

	 	(a)	 	Latham & Watkins LLP, counsel for the Purchasers, shall have furnished to the
Representative its opinion and negative assurance letter, in each case dated the Time of
Delivery, in form and substance acceptable to the Representative, and such counsel shall
have received such papers and information as they may reasonably request to enable them to
pass upon such matters;
	 
	 	(b)	 	(i) Skadden, Arps, Slate, Meagher & Flom LLP, counsel for the Company and the
Guarantors, shall have furnished to the Representative their written opinions and negative
assurance letter, dated the Time of Delivery, satisfactory to the Representative and
substantially in the form set forth in Exhibit A hereto; and (ii) Kristin Kolesar,
Senior Vice

12

 

	 	 	 	President and Global General Counsel, Operations of the Company shall have furnished to
the Representative her written opinion, dated the Time of Delivery, satisfactory to the
Representative and substantially in the form set forth in Exhibit B hereto;
	 
	 	(c)	 	On the date of the Offering Circular prior to the execution of this Agreement and also
at the Time of Delivery, Deloitte & Touche LLP shall have furnished to you a letter or
letters, dated the respective dates of delivery thereof, in form and substance satisfactory
to you;
	 
	 	(d)	 	(i) Neither the Company nor any of its subsidiaries shall have sustained since the date
of the latest audited financial statements included in the Pricing Circular any loss or
interference with its business from fire, explosion, flood or other calamity, whether or
not covered by insurance, or from any labor dispute or court or governmental action, order
or decree, otherwise than as set forth or contemplated in the Pricing Circular and the
Offering Circular, and (ii) since the respective dates as of which information is given in
the Pricing Circular and the Offering Circular there shall not have been any change in the
capital stock or long-term debt of the Company or any of its subsidiaries or any change, or
any development involving a prospective change, in or affecting the general affairs,
management, financial position, stockholders’ equity or results of operations of the
Company and its subsidiaries, otherwise than as set forth or contemplated in the Pricing
Circular and the Offering Circular, the effect of which, in any such case described in
clause (i) or (ii), is in your judgment so material and adverse as to make it impracticable
or inadvisable to proceed with the offering or the delivery of the Securities on the terms
and in the manner contemplated in this Agreement and in the Offering Circular;
	 
	 	(e)	 	On or after the Applicable Time (i) no downgrading shall have occurred in the rating
accorded the Company’s outstanding indebtedness by any “nationally recognized statistical
rating organization”, as that term is defined by the Commission for purposes of Rule
436(g)(2) under the Securities Act, and (ii) no such organization shall have publicly
announced that it has under surveillance or review, with possible negative implications,
its rating of any of the Company’s outstanding indebtedness;
	 
	 	(f)	 	On or after the Applicable Time there shall not have occurred any of the following: (i)
a suspension or material limitation in trading in securities generally on the New York
Stock Exchange or on NASDAQ; (ii) a suspension or material limitation in trading in the
Company’s securities on NASDAQ; (iii) a general moratorium on commercial banking activities
declared by either Federal or New York State authorities or a material disruption in
commercial banking or securities settlement or clearance services in the United States;
(iv) the outbreak or escalation of hostilities involving the United States or the
declaration by the United States of a national emergency or war or (v) the occurrence of
any other calamity or crisis or any change in financial, political or economic conditions
in the United States or elsewhere, if the effect of any such event specified in clause (iv)
or (v) in your judgment makes it impracticable or inadvisable to proceed with the offering
or the delivery of the Securities on the terms and in the manner contemplated in the
Offering Circular; and
	 
	 	(g)	 	The Company and the Guarantors shall have furnished or caused to be furnished to you at
the Time of Delivery certificates of officers of the Company and the Guarantors
satisfactory to you as to the accuracy of the representations and warranties of the Company
and the Guarantors herein at and as of such Time of Delivery, as to the performance by the
Company and the Guarantors of all of their obligations hereunder to be performed at or
prior to such Time of Delivery, as to the matters set forth in subsection (d) of this
Section and as to such other matters as you may reasonably request.

13

 

	9.	(a)	 	The Company and the Guarantors will, jointly and severally, indemnify and hold harmless
each Purchaser against any losses, claims, damages or liabilities, joint or several, to which
such Purchaser may become subject, under the Securities Act or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are
based upon an untrue statement or alleged untrue statement of a material fact contained in any
Preliminary Offering Circular, the Pricing Circular, the Offering Circular, or any amendment
or supplement thereto, any Company Supplemental Disclosure Document, or arise out of or are
based upon the omission or alleged omission to state therein a material fact necessary to make
the statements therein not misleading, and will reimburse each Purchaser for any legal or
other expenses reasonably incurred by such Purchaser in connection with investigating or
defending any such action or claim as such expenses are incurred; provided, however, that the
Company shall not be liable in any such case to the extent that any such loss, claim, damage
or liability arises out of or is based upon an untrue statement or alleged untrue statement or
omission or alleged omission made in any Preliminary Offering Circular, the Pricing Circular,
the Offering Circular or any such amendment or supplement, or any Company Supplemental
Disclosure Document, in reliance upon and in conformity with written information furnished to
the Company by any Purchaser through the Representative expressly for use therein.
	 
	 	(b)	 	Each Purchaser will, severally and not jointly, indemnify and hold harmless the Company
and the Guarantors against any losses, claims, damages or liabilities to which such parties
may become subject, under the Securities Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based upon an
untrue statement or alleged untrue statement of a material fact contained in any
Preliminary Offering Circular, the Pricing Circular, the Offering Circular, or any
amendment or supplement thereto, or any Company Supplemental Disclosure Document, or arise
out of or are based upon the omission or alleged omission to state therein a material fact
or necessary to make the statements therein not misleading, in each case to the extent, but
only to the extent, that such untrue statement or alleged untrue statement or omission or
alleged omission was made in any Preliminary Offering Circular, the Pricing Circular, the
Offering Circular or any such amendment or supplement, or any Company Supplemental
Disclosure Document in reliance upon and in conformity with written information furnished
to the Company or any Guarantor by such Purchaser through the Representative expressly for
use therein; and each Purchaser will reimburse the Company and the Guarantors for any legal
or other expenses reasonably incurred by the Company or the Guarantors in connection with
investigating or defending any such action or claim as such expenses are incurred.
	 
	 	(c)	 	Promptly after receipt by an indemnified party under subsection (a) or (b) above of
notice of the commencement of any action, such indemnified party shall, if a claim in
respect thereof is to be made against the indemnifying party under such subsection, notify
the indemnifying party in writing of the commencement thereof; but the omission so to
notify the indemnifying party shall not relieve it from any liability which it may have to
any indemnified party otherwise than under such subsection. In case any such action shall
be brought against any indemnified party and it shall notify the indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate therein and,
to the extent that it shall wish, jointly with any other indemnifying party similarly
notified, to assume the defense thereof, with counsel satisfactory to such indemnified
party (who shall not, except with the consent of the indemnified party, be counsel to the
indemnifying party), and, after notice from the

14

 

	 	 	 	indemnifying party to such indemnified party of its election so to assume the defense
thereof, the indemnifying party shall not be liable to such indemnified party under such
subsection for any legal expenses of other counsel or any other expenses, in each case
subsequently incurred by such indemnified party, in connection with the defense thereof
other than reasonable costs of investigation. No indemnifying party shall, without the
written consent of the indemnified party, effect the settlement or compromise of, or
consent to the entry of any judgment with respect to, any pending or threatened action or
claim in respect of which indemnification or contribution may be sought hereunder (whether
or not the indemnified party is an actual or potential party to such action or claim)
unless such settlement, compromise or judgment (i) includes an unconditional release of
the indemnified party from all liability arising out of such action or claim and (ii) does
not include a statement as to, or an admission of, fault, culpability or a failure to act,
by or on behalf of any indemnified party.
	 
	 	(d)	 	If the indemnification provided for in this Section 9 is unavailable to or insufficient
to hold harmless an indemnified party under subsection (a) or (b) above in respect of any
losses, claims, damages or liabilities (or actions in respect thereof) referred to therein,
then each indemnifying party shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, claims, damages or liabilities (or actions in
respect thereof) in such proportion as is appropriate to reflect the relative benefits
received by the Company and the Guarantors on the one hand and the Purchasers on the other
from the offering of the Securities. If, however, the allocation provided by the
immediately preceding sentence is not permitted by applicable law or if the indemnified
party failed to give the notice required under subsection (c) above, then each indemnifying
party shall contribute to such amount paid or payable by such indemnified party in such
proportion as is appropriate to reflect not only such relative benefits but also the
relative fault of the Company and the Guarantors on the one hand and the Purchasers on the
other in connection with the statements or omissions which resulted in such losses, claims,
damages or liabilities (or actions in respect thereof), as well as any other relevant
equitable considerations. The relative benefits received by the Company and the Guarantors
on the one hand and the Purchasers on the other shall be deemed to be in the same
proportion as the total net proceeds from the offering (before deducting expenses) received
by the Company and the Guarantors bear to the total underwriting discounts and commissions
received by the Purchasers, in each case as set forth in the Offering Circular. The
relative fault shall be determined by reference to, among other things, whether the untrue
or alleged untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company and the Guarantors on the
one hand or the Purchasers on the other and the parties’ relative intent, knowledge, access
to information and opportunity to correct or prevent such statement or omission. The
Company, the Guarantors and the Purchasers agree that it would not be just and equitable if
contribution pursuant to this subsection (d) were determined by pro rata allocation (even
if the Purchasers were treated as one entity for such purpose) or by any other method of
allocation which does not take account of the equitable considerations referred to above in
this subsection (d). The amount paid or payable by an indemnified party as a result of the
losses, claims, damages or liabilities (or actions in respect thereof) referred to above in
this subsection (d) shall be deemed to include any legal or other expenses reasonably
incurred by such indemnified party in connection with investigating or defending any such
action or claim. Notwithstanding the provisions of this subsection (d), no Purchaser shall
be required to contribute any amount in excess of the amount by which the total price at
which the Securities underwritten by it and distributed to

15

 

	 	 	 	investors were offered to investors exceeds the amount of any damages which such Purchaser
has otherwise been required to pay by reason of such untrue or alleged untrue statement or
omission or alleged omission. The Purchasers’ obligations in this subsection (d) to
contribute are several in proportion to their respective purchase obligations and not
joint.
	 
	 	(e)	 	The obligations of the Company and the Guarantors under this Section 9 shall be in
addition to any liability which the Company and the Guarantors may otherwise have and shall
extend, upon the same terms and conditions, to any affiliate of each Purchaser and each
person, if any, who controls any Purchaser within the meaning of the Securities Act; and
the obligations of the Purchasers under this Section 9 shall be in addition to any
liability which the respective Purchasers may otherwise have and shall extend, upon the
same terms and conditions, to each officer and director of the Company or any Guarantor and
to each person, if any, who controls the Company or any Guarantor within the meaning of the
Securities Act.
	 
	10.	(a)	 	If any Purchaser shall default in its obligation to purchase the Securities which it has
agreed to purchase hereunder, you may in your discretion arrange for you or another party or
other parties to purchase such Securities on the terms contained herein. If within thirty-six
hours after such default by any Purchaser you do not arrange for the purchase of such
Securities, then the Company shall be entitled to a further period of thirty-six hours within
which to procure another party or other parties satisfactory to you to purchase such
Securities on such terms. In the event that, within the respective prescribed periods, you
notify the Company that you have so arranged for the purchase of such Securities, or the
Company notifies you that it has so arranged for the purchase of such Securities, you or the
Company shall have the right to postpone the Time of Delivery for a period of not more than
seven days, in order to effect whatever changes may thereby be made necessary in the Offering
Circular, or in any other documents or arrangements, and the Company agrees to prepare
promptly any amendments to the Offering Circular which in your opinion may thereby be made
necessary. The term “Purchaser” as used in this Agreement shall include any person
substituted under this Section with like effect as if such person had originally been a party
to this Agreement with respect to such Securities.
	 
	 	(b)	 	If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Purchaser or Purchasers by you and the Company as provided in subsection (a)
above, the aggregate principal amount of such Securities which remains unpurchased does not
exceed one-eleventh of the aggregate principal amount of all the Securities, then the
Company shall have the right to require each non-defaulting Purchaser to purchase the
principal amount of Securities which such Purchaser agreed to purchase hereunder and, in
addition, to require each non-defaulting Purchaser to purchase its pro rata share (based on
the principal amount of Securities which such Purchaser agreed to purchase hereunder) of
the Securities of such defaulting Purchaser or Purchasers for which such arrangements have
not been made; but nothing herein shall relieve a defaulting Purchaser from liability for
its default.
	 
	 	(c)	 	If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Purchaser or Purchasers by you and the Company as provided in subsection (a)
above, the aggregate principal amount of Securities which remains unpurchased exceeds
one-eleventh of the aggregate principal amount of all the Securities, or if the Company
shall not exercise the right described in subsection (b) above to require non-defaulting
Purchasers to purchase Securities of a defaulting Purchaser or Purchasers, then this
Agreement shall thereupon

16

 

	 	 	 	terminate, without liability on the part of any non-defaulting Purchaser or the Company,
except for the expenses to be borne by the Company and the Purchasers as provided in
Section 7 hereof and the indemnity and contribution agreements in Section 9 hereof; but
nothing herein shall relieve a defaulting Purchaser from liability for its default.

	11.	 	The respective indemnities, agreements, representations, warranties and other statements of
the Company, the Guarantors and the several Purchasers, as set forth in this Agreement or made
by or on behalf of them, respectively, pursuant to this Agreement, shall remain in full force
and effect, regardless of any investigation (or any statement as to the results thereof) made
by or on behalf of any Purchaser or any controlling person of any Purchaser, or the Company or
any Guarantor, or any officer or director or controlling person of the Company or any
Guarantor, and shall survive delivery of and payment for the Securities.
	 
	12.	 	If this Agreement shall be terminated pursuant to Section 10 hereof, the Company and the
Guarantors shall not then be under any liability to any Purchaser except as provided in
Sections 7 and 9 hereof; but, if for any other reason, the Securities are not delivered by or
on behalf of the Company and the Guarantors as provided herein, the Company and the Guarantors
will reimburse the Purchasers through you for all expenses approved in writing by you,
including fees and disbursements of counsel, reasonably incurred by the Purchasers in making
preparations for the purchase, sale and delivery of the Securities, but the Company and the
Guarantors shall then be under no further liability to any Purchaser except as provided in
Sections 7 and 9 hereof.
	 
	13.	 	In all dealings hereunder, you shall act on behalf of each of the Purchasers, and the parties
hereto shall be entitled to act and rely upon any statement, request, notice or agreement on
behalf of any Purchaser made or given by the Representative.

All statements, requests, notices and agreements hereunder shall be in writing, and if to the
Purchasers shall be delivered or sent by mail, telex or facsimile transmission to you as the
representative at 200 West Street, New York, New York 10282-2198, Attention: Registration
Department; and if to the Company shall be delivered or sent by mail, telex or facsimile
transmission to the address of the Company set forth in the Offering Circular, Attention:
Secretary; provided, however, that any notice to a Purchaser pursuant to Section 9 hereof shall be
delivered or sent by mail, telex or facsimile transmission to such Purchaser at its address set
forth in its Purchasers’ Questionnaire, or telex constituting such Questionnaire, which address
will be supplied to the Company by you upon request. Any such statements, requests, notices or
agreements shall take effect upon receipt thereof.

In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed
into law October 26, 2001)), the Purchasers are required to obtain, verify and record information
that identifies their respective clients, including the Company, which information may include the
name and address of their respective clients, as well as other information that will allow the
Purchasers to properly identify their respective clients.

	14.	 	This Agreement shall be binding upon, and inure solely to the benefit of, the Purchasers, the
Company, the Guarantors and, to the extent provided in Sections 9 and 11 hereof, the officers
and directors of the Company and the Guarantors and each person who controls the Company, any
Guarantor or any Purchaser, and their respective heirs, executors, administrators, successors
and assigns, and no other person shall acquire or have any right under or by virtue of this
Agreement. No purchaser of any of the Securities from any Purchaser shall be deemed a
successor or assign by reason merely of such purchase.

17

 

	15.	 	Time shall be of the essence of this Agreement.

	16.	 	The Company and each Guarantor acknowledge and agree that (i) the purchase and sale of the
Securities pursuant to this Agreement is an arm’s-length commercial transaction between the
Company and the Guarantors, on the one hand, and the several Purchasers, on the other, (ii) in
connection therewith and with the process leading to such transaction each Purchaser is acting
solely as a principal and not the agent or fiduciary of the Company or any Guarantor, (iii) no
Purchaser has assumed an advisory or fiduciary responsibility in favor of the Company or any
Guarantor with respect to the offering contemplated hereby or the process leading thereto
(irrespective of whether such Purchaser has advised or is currently advising the Company or
any Guarantor on other matters) or any other obligation to the Company or any Guarantor except
the obligations expressly set forth in this Agreement and (iv) the Company and the Guarantors
have consulted their own legal and financial advisors to the extent they have deemed
appropriate. The Company and the Guarantors agree that they will not claim that the
Purchasers, or any of them, have rendered advisory services of any nature or respect, or owe a
fiduciary or similar duty to the Company or any Guarantor, in connection with such transaction
or the process leading thereto.

	17.	 	This Agreement supersedes all prior agreements and understandings (whether written or oral)
between the Company, the Guarantors and the Purchasers, or any of them, with respect to the
subject matter hereof.

	18.	 	THIS AGREEMENT AND ANY MATTERS RELATED TO THIS TRANSACTION SHALL BE GOVERNED BY AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICT
OF LAWS THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAWS OF THE STATE OF
NEW YORK. The Company and the Guarantors agree that any suit or proceeding arising in respect
of this agreement or our engagement will be tried exclusively in the U.S. District Court for
the Southern District of New York or, if that court does not have subject matter jurisdiction,
in any state court located in The City and County of New York and the Company agrees to submit
to the jurisdiction of, and to venue in, such courts.

	19.	 	The Company, the Guarantors and each of the Purchasers hereby irrevocably waive, to the
fullest extent permitted by applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.

	20.	 	This Agreement may be executed by any one or more of the parties hereto in any number of
counterparts, each of which shall be deemed to be an original, but all such respective
counterparts shall together constitute one and the same instrument.

	21.	 	Notwithstanding anything herein to the contrary, the Company (and the Company’s employees,
representatives, and other agents) are authorized to disclose to any and all persons, the tax
treatment and tax structure of the potential transaction and all materials of any kind
(including tax opinions and other tax analyses) provided to the Company relating to that
treatment and structure, without the Purchasers’ imposing any limitation of any kind.
However, any information relating to the tax treatment and tax structure shall remain
confidential (and the foregoing sentence shall not apply) to the extent necessary to enable
any person to comply with securities laws. For this purpose, “tax treatment” means US federal
and state income tax treatment, and “tax structure” is limited to any facts that may be
relevant to that treatment.

[Remainder of page intentionally left blank]

18

 

If the foregoing is in accordance with your understanding, please sign and return to us
counterparts hereof, and upon the acceptance hereof by you, on behalf of each of the Purchasers,
this letter and such acceptance hereof shall constitute a binding agreement among each of the
Purchasers and the Company and each Guarantor.

	 	 	 	 	 
	 	Very truly yours,

MYLAN INC.

 	 
	 	By:  	 
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	SVP & Global GC, Operations 	 
	 
	 	BERTEK INTERNATIONAL, INC.

 	 
	 	By:  	 
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	DEY, INC.

 	 
	 	By:  	 
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	DEY PHARMA, L.P., by Dey, Inc., its GP

 	 
	 	By:  	 
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	
DEY LIMITED PARTNER, INC.

 	 
	 	By:  	 
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	
EMD, INC.

 	 
	 	By:  	 
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 

19

 

	 	 	 	 	 

	 	 	 	 	 
	 	

MLRE LLC

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Manager 	 
	 
	 	
MP AIR INC.

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	MYLAN BERTEK PHARMACEUTICALS INC.

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	MYLAN CARIBE, INC.

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	MYLAN DELAWARE INC.

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	
MYLAN LLC

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Manager 	 

20

 

	 	 	 	 	 

	 	 	 	 	 
	 	

MYLAN LHC INC.

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	
MYLAN PHARMACEUTICALS INC.

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	MYLAN TECHNOLOGIES INC.

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 
	 	UDL LABORATORIES, INC.

 	 
	 	By:  	
 	 
	 	 	Name:  	Kristin Kolesar 	 
	 	 	Title:  	Secretary 	 
	 

	 	 	 	 	 
	 	Accepted as of the date hereof:

GOLDMAN, SACHS & CO.

 	 
	 	By:  	
 	 
	 	 	(Goldman, Sachs & Co.)
 	 
	 	 	On behalf of each of the Purchasers 	 

21Exhibit 10.1

Exhibit 10.1

Execution Copy

THIRD AMENDMENT

TO LETTER OF CREDIT AGREEMENT

THIS THIRD AMENDMENT
TO LETTER OF CREDIT AGREEMENT (this “Amendment”) is dated as of July 23,
2010 and is entered into by and among UTi Worldwide Inc., a BVI Business Company incorporated under
the laws of the British Virgin Islands with company number 141257 (the “Company”), each of the
Subsidiary Guarantors (as defined in the Letter of Credit Agreement), Nedbank Limited, acting
through its London Branch (the “Issuing Bank”), and is made with reference to that certain LETTER
OF CREDIT AGREEMENT dated as of July 9, 2009 (as amended by the First Amendment to Letter of Credit
Agreement among the Company, the Subsidiary Guarantors and the Issuing Bank, dated as of January 8,
2010 and the Second Amendment to Letter of Credit Agreement among the Company, the Subsidiary
Guarantors and the Issuing Bank, dated as of March 25, 2010, the “Letter of Credit Agreement”) by
and among the Company, the Subsidiary Guarantors and the Issuing Bank. Capitalized terms used
herein without definition shall have the same meanings herein as set forth in the Letter of Credit
Agreement after giving effect to this Amendment.

RECITALS

WHEREAS, the Obligors have requested that the Issuing Bank agree to amend certain provisions
of the Letter of Credit Agreement as provided for herein; and

WHEREAS, subject to certain conditions, the Issuing Bank is willing to agree to such amendment
relating to the Letter of Credit Agreement.

NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants
herein contained, the parties hereto agree as follows:

SECTION I. AMENDMENTS TO LETTER OF CREDIT AGREEMENT

A. The cover page of the Letter of Credit Agreement is hereby amended by replacing “U.S.
$36,000,000” with “U.S. $61,000,000”.

B. The first page of the Letter of Credit Agreement is hereby amended by replacing “U.S.
$36,000,000” with “U.S. 61,000,000”.

C. The last subclause (ii) in the second sentence of the first paragraph of Section 1.1 of the
Letter of Credit Agreement is hereby amended and restated in its entirety as follows:

(ii) in no event shall any Letter of Credit issued after July 23, 2010 have
an expiration date later than the Maturity Date unless agreed to by the
Issuing Bank.

D. The definition of “Maximum Draw Amount” in Schedule B to the Letter of Credit Agreement is
hereby amended and restated in its entirety as follows:

“Maximum Draw Amount” means $61,000,000.

 

 

 

SECTION II. CONDITIONS TO EFFECTIVENESS

This Amendment shall become effective as of the date hereof only upon the satisfaction of all
of the following conditions precedent (the date of satisfaction of such conditions being referred
to herein as the “Third Amendment Effective Date”):

A. Execution. The Issuing Bank shall have received a counterpart signature page of this
Amendment duly executed by each of the Obligors.

B. Fees. The Issuing Bank shall have received (i) a nonrefundable arrangement fee equal to
$162,500 and (ii) all fees and other amounts due and payable on or prior to the Third Amendment
Effective Date, including, to the extent invoiced, reimbursement or other payment of all
out-of-pocket expenses required to be reimbursed or paid by the Company hereunder or under any
other Financing Agreement.

C. Necessary Consents. Each Obligor shall have obtained all material consents necessary or
advisable in connection with the transactions contemplated by this Amendment.

D. Opinions of Counsel; Registered Agent’s Certificate. The Issuing Bank shall have received
(i) an executed copy of a written opinion of Harneys Westwood & Riegels, British Virgin Islands
counsel for the Obligors covering the existence and good standing of the Company, the capacity and
power of the Company to perform its obligations pursuant to the Amendment, the due execution by the
Company of the Amendment, matters related to enforceability, no-conflict, and choice of law and
including other matters incident to the transactions contemplated hereby and otherwise in form and
substance reasonably satisfactory to the Issuing Bank; (ii) an executed copy of a written opinion
of Latham & Watkins LLP, English counsel for the Issuing Bank, each addressed to the Issuing Bank,
dated as of the Third Amendment Effective Date, covering matters related to enforceability and
choice of law of the Amendment including other matters incident to the transactions contemplated
hereby and otherwise in form and substance reasonably satisfactory to the Issuing Bank; and (iii) a
copy of the certificate identifying the directors and shareholders of the Company and executed by
Midocean Management and Trust Services (BVI) Limited, as registered agent of the Company, dated
July 23, 2010.

E. Other Documents. The Issuing Bank shall have received such other documents, information or
agreements regarding Obligors as the Issuing Bank may reasonably request.

SECTION III. REPRESENTATIONS AND WARRANTIES

In order to induce the Issuing Bank to enter into this Amendment and to amend the Letter of
Credit Agreement in the manner provided herein, each Obligor which is a party hereto represents and
warrants to the Issuing Bank that the following statements are true and correct in all material
respects:

A. Organization; Power and Authority. Each Obligor is a corporation or other legal entity
duly incorporated or organized, validly existing and, where legally applicable, in good
standing under the laws of its jurisdiction of incorporation, and is duly qualified as a
foreign corporation or other legal entity, where applicable, and, where legally applicable, is in
good standing in each jurisdiction in which such qualification is required by law, other than those
jurisdictions as to which the failure to be so qualified or in good standing would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Each
Obligor has the corporate (or other organizational) power and authority to own or hold under lease
the properties it purports to own or hold under lease, to transact the business it transacts and
proposes to transact, to execute and deliver the Letter of Credit Agreement as amended by this
Amendment (the “Amended Agreement”) to which it is a party and to perform the provisions hereof.

 

2

 

B. Authorization, Etc. The Amendment has been duly authorized by all necessary corporate or
other entity action on the part of each Obligor, and the Amendment constitutes a legal, valid and
binding obligation of each Obligor party thereto enforceable against any such Obligor in accordance
with its terms, except as such enforceability may be limited by (i) applicable bankruptcy,
insolvency, reorganization, moratorium or other similar laws affecting the enforcement of
creditors’ rights generally and (ii) general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or at law).

C. No Conflict. The execution, delivery and performance by each Obligor of the Amendment will
not (a) contravene, result in any breach of, or constitute a default under, or result in the
creation of any Lien in respect of any property of any Obligor or any Subsidiary under, any
indenture, mortgage, deed of trust, loan, purchase or credit agreement, lease, corporate charter,
memorandum and articles of association, regulations or by-laws, or any other agreement or
instrument to which any Obligor or any Subsidiary is bound or by which any Obligor or any
Subsidiary or any of their respective properties may be bound or affected, (b) conflict with or
result in a breach of any of the terms, conditions or provisions of any order, judgment, decree, or
ruling of any court, arbitrator or Governmental Authority applicable to any Obligor or any
Subsidiary, except for such conflicts or breaches that would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect or (c) violate any provision of any
statute or other rule or regulation of any Governmental Authority applicable to any Obligor or any
Subsidiary, in each case, except for such contraventions, breaches, defaults, Liens, conflicts and
violations that would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.

D. Governmental Authorizations, Etc. Except as disclosed on Schedule 5.7 of the Amended
Agreement, no consent, approval or authorization of, or registration, filing or declaration with,
any Governmental Authority is required in connection with the execution, delivery or performance by
any Obligor of the Amendment or the Amended Agreement, including, without limitation, any thereof
required in connection with the obtaining of Dollars to make payments under the Amended Agreement
or any other Financing Agreement and the payment of such Dollars to Persons resident in the United
States of America. Except as disclosed on Schedule 5.7 of the Amended Agreement, it is not
necessary to ensure the legality, validity, enforceability or admissibility into evidence in the
Applicable Jurisdiction of the Amended Agreement or any other Financing Agreement that any thereof
or any other document be filed, recorded or enrolled with any Governmental Authority, or that any
such agreement or document be stamped with any stamp, registration or similar transaction tax.

 

3

 

E. Insolvency. As of the Third Amendment Effective Date:

(a) no Obligor, is unable, or is deemed to be unable for the purposes of any applicable law,
or admits or has admitted its inability, to pay its debts as and when they fall due or has
suspended, or announced an intention to suspend, making payments on any of its debts;

(b) no Obligor, by reason of actual or anticipated financial difficulties has begun
negotiations with one or more of its creditors with a view to rescheduling or restructuring any of
its Indebtedness; and

(c) no moratorium has been declared in respect of any Indebtedness of any Obligor.

F. Incorporation of Representations and Warranties from Letter of Credit Agreement. The
representations and warranties contained in Section 5 of the Letter of Credit Agreement are and
will be true and correct in all material respects on and as of the Third Amendment Effective Date
to the same extent as though made on and as of that date, except to the extent such representations
and warranties specifically relate to an earlier date, in which case they were true and correct in
all material respects on and as of such earlier date.

G. Absence of Default. No event has occurred and is continuing or will result from the
consummation of the transactions contemplated by this Amendment that would constitute an Event of
Default or a Default.

SECTION IV. ACKNOWLEDGMENT AND CONSENT

Each Subsidiary Guarantor hereby acknowledges that it has reviewed the terms and provisions of
the Letter of Credit Agreement and this Amendment and consents to the amendment of the Letter of
Credit Agreement effected pursuant to this Amendment. Each Subsidiary Guarantor hereby confirms
that each Financing Agreement to which it is a party or otherwise bound will continue to guarantee
to the fullest extent possible in accordance with the Financing Agreements the payment and
performance of all “Obligations” and “Guaranteed Obligations” under each of the Financing
Agreements to which is a party (in each case as such terms are defined in the Letter of Credit
Agreement).

Each Subsidiary Guarantor acknowledges and agrees that any of the Financing Agreements to
which it is a party or otherwise bound shall continue in full force and effect and that all of its
obligations thereunder shall be valid and enforceable and shall not be impaired or limited by the
execution or effectiveness of this Amendment. Each Subsidiary Guarantor represents and warrants
that all representations and warranties contained in the Amended Agreement and the Financing
Agreements to which it is a party or otherwise bound are true and correct in all material respects
on and as of the Third Amendment Effective Date to the same extent as though made on and as of that
date, except to the extent such representations and warranties specifically relate to an earlier
date, in which case they were true and correct in all material respects on and as of such earlier
date.

 

4

 

SECTION V. MISCELLANEOUS

A. Reference to and Effect on the Letter of Credit Agreement and the Other Financing
Agreements.

(i) On and after the Third Amendment Effective Date, each reference in the
Letter of Credit Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or
words of like import referring to the Letter of Credit Agreement, and each reference
in the other Financing Agreements to the “Agreement”, “thereunder”, “thereof” or
words of like import referring to the Letter of Credit Agreement shall mean and be a
reference to the Letter of Credit Agreement as amended by this Amendment.

(ii) Except as specifically amended by this Amendment, the Letter of Credit
Agreement and the other Financing Agreements shall remain in full force and effect
and are hereby ratified and confirmed.

(iii) The execution, delivery and performance of this Amendment shall not
constitute a waiver of any provision of, or operate as a waiver of any right, power
or remedy of the Issuing Bank under, the Letter of Credit Agreement or any of the
other Financing Agreements.

B. Headings. Section and Subsection headings in this Amendment are included herein for
convenience of reference only and shall not constitute a part of this Amendment for any other
purpose or be given any substantive effect.

C. Applicable Law. THIS AMENDMENT AND ANY NON-CONTRACTUAL OBLIGATIONS ARISING OUT OF OR IN
CONNECTION WITH IT ARE GOVERNED BY ENGLISH LAW.

D. Jurisdiction.

(1) The courts of England have exclusive jurisdiction to settle any dispute arising out
of or in connection with this Amendment (including a dispute relating to the existence,
validity or termination of this Amendment or any non-contractual obligation arising out of
or in connection with this Amendment ) (a “Dispute”).

(2) The parties hereto agree that the courts of England are the most appropriate and
convenient courts to settle Disputes and accordingly no party to this Amendment will argue
to the contrary.

(3) This Section V.D. is for the benefit of the Issuing Bank only. As a result, the
Issuing Bank shall not be prevented from taking proceedings relating to a Dispute in any
other courts with jurisdiction. To the extent allowed by law, the Issuing Bank may take
concurrent proceedings in any number of jurisdictions.

E. Counterparts. This Amendment may be executed in any number of counterparts and by
different parties hereto in separate counterparts, each of which when so executed and
delivered shall be deemed an original, but all such counterparts together shall constitute but
one and the same instrument; signature pages may be detached from multiple separate counterparts
and attached to a single counterpart so that all signature pages are physically attached to the
same document.

[Remainder of this page intentionally left blank.]

 

5

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered
by their respective officers thereunto duly authorized as of the date first written above.

	 	 	 	 	 
	COMPANY:  	UTi WORLDWIDE INC.

 	 
	 	By:  	                                   /s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	SUBSIDIARY GUARANTORS: 	UTI (AUST) PTY LIMITED, ABN 48 006 734 747

 
	 	By:  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI AFRICA SERVICES LIMITED

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UNIGISTIX INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI, CANADA, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI CANADA HOLDINGS, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	SPAN MANUFACTURING LIMITED

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	 	UTI DEUTSCHLAND GMBH

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI (HK) LTD.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI NEDERLAND B.V.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	SERVICIOS LOGISTICOS INTEGRADOS SLI, S.A.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UNIÓN DE SERVICIOS LOGÍSTICOS INTEGRADOS, S.A.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI SPAIN S.A.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	 	UTI (TAIWAN) LIMITED

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI LOGISTICS (TAIWAN) LTD.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI WORLDWIDE (UK) LIMITED

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI, (U.S.) HOLDINGS, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI, UNITED STATES, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI, SERVICES, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	 	UTI BROKERAGE, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI LOGISTICS, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	VANGUARD CARGO SYSTEMS, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI INTEGRATED LOGISTICS, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	MARKET INDUSTRIES, LTD.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	MARKET TRANSPORT, LTD

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	 	TRIPLE EXPRESS, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	INTRANSIT, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	MARKET LOGISTICS SERVICES, LTD.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	MARKET LOGISTICS BROKERAGE, LTD.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	SAMMONS TRANSPORTATION, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	LAKE STATES TRUCKING, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	 	CONCENTREK, INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UNITED EXPRESS, LTD.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	AFRICAN INVESTMENTS B.V.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	 	UTI ASIA PACIFIC LIMITED

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	GODDARD COMPANY LIMITED

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI INTERNATIONAL INC.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI (N.A.) HOLDINGS N.V.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI (NETHERLANDS) HOLDINGS B.V.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	PYRAMID FREIGHT (PROPRIETARY) LIMITED

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	 	UTI LOGISTICS N.V.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 
	 	UTI NEW ZEALAND LTD.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

	 	 	 	 	 
	 	UTI IRELAND LIMITED

Signed, Sealed and Delivered by

 	 
	 	/s/ Craig Braun
 	 
	 	Craig Braun, 	 
	 	duly appointed attorney

for and on behalf of

UTi IRELAND LIMITED

in the presence of: 	 
	 
	 	 	 
	 	Witness:  	/s/ John Thurso Barendse
 	 
	 	Name:  	John Thurso Barendse 	 
	 	Address:  	               100 Oceangate, Suite 1500

Long Beach, CA 	 
	 	Occupation:  	VP Global Performance Analysis 	 
	 

	 	 	 	 	 
	 	UTI WORLDWIDE (SINGAPORE) PTE LTD.

 	 
	 	By  	/s/ Craig Braun
 	 
	 	 	Authorized Signatory 	 
	 	 	 	 

[Signature Page to Third Amendment]

 

 

 

	 	 	 	 	 
	 	NEDBANK LIMITED, acting through its London Branch,
As Issuing Bank

 	 
	 	By:  	/s/ Christo Roets
 	 
	 	 	Name:  	Christo Roets 	 
	 	 	Title:  	Authorized Signatory 	 
	 
	 	 	 
	 	By:  	                                      /s/ Graham Hardy
 	 
	 	 	Name:  	Graham Hardy 	 
	 	 	Title:  	Authorized Signatory 	 
	 

[Signature Page to Third Amendment]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}]]